丰倍生物
(603334)
| 流通市值：10.21亿 | | | 总市值：46.03亿 |
| 流通股本：3181.67万 | | | 总股本：1.44亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 335,729,013.7 | 662,577,172.33 | 567,157,391.04 | 106,015,042.8 |
| 交易性金融资产 | 330,000,000 | 130,004,974.2 | 300,141,723.04 | 13,362.68 |
| 应收票据及应收账款 | 455,493,934.36 | 190,732,000.27 | 231,827,513.88 | 243,768,031.67 |
| 其中：应收票据 | 76,593,153.15 | 44,691,723.42 | 59,241,556.25 | 45,277,000.85 |
| 应收账款 | 378,900,781.21 | 146,040,276.85 | 172,585,957.63 | 198,491,030.82 |
| 应收款项融资 | 64,892,644.28 | 45,334,654.81 | 12,862,336.23 | 46,494,218.31 |
| 预付款项 | 40,835,357.67 | 145,028,979.68 | 43,911,971.98 | 127,026,269.05 |
| 其他应收款合计 | 13,659,050.38 | 13,026,820 | 12,366,438.25 | 12,154,892.73 |
| 存货 | 472,714,671.94 | 453,658,476.47 | 522,601,983.74 | 368,414,843.94 |
| 合同资产 | 3,885,500 | 4,505,898.61 | 4,505,898.61 | 6,385,212.41 |
| 其他流动资产 | 12,423,650.16 | 25,108,419.9 | 31,907,618.43 | 27,210,483.54 |
| 流动资产合计 | 1,729,633,822.49 | 1,669,977,396.27 | 1,727,282,875.2 | 937,482,357.13 |
| 非流动资产: | | | | |
| 固定资产 | 391,762,771.52 | 386,309,347.22 | 389,868,420.82 | 277,191,036.76 |
| 在建工程 | 16,759,934.27 | 26,587,850.31 | 25,201,303.41 | 142,734,084.23 |
| 使用权资产 | 1,339,203.63 | 1,575,533.67 | 1,811,863.71 | 4,613,148.77 |
| 无形资产 | 62,395,854.11 | 62,770,932.32 | 63,066,364.5 | 58,440,401.35 |
| 商誉 | 17,176.8 | 17,176.8 | 17,176.8 | - |
| 长期待摊费用 | 1,562,550.84 | 1,668,353.94 | 1,622,014.62 | 1,615,481.98 |
| 递延所得税资产 | 12,693,201.75 | 11,457,108.36 | 11,655,955.77 | 9,984,853.76 |
| 其他非流动资产 | 33,477,796.6 | 6,086,957.6 | 4,818,356.73 | 3,793,127.39 |
| 非流动资产合计 | 520,008,489.52 | 496,473,260.22 | 498,061,456.36 | 498,372,134.24 |
| 资产总计 | 2,249,642,312.01 | 2,166,450,656.49 | 2,225,344,331.56 | 1,435,854,491.37 |
| 流动负债: | | | | |
| 短期借款 | 229,835,710.57 | 122,273,641.03 | 222,713,829.84 | 259,605,336.08 |
| 交易性金融负债 | 139,299.99 | 305,770.33 | 258,500.64 | 185,451.24 |
| 应付票据及应付账款 | 198,460,396.83 | 158,709,524.64 | 168,292,594.69 | 139,141,288 |
| 其中：应付票据 | 36,338,983.13 | 38,082,701.61 | 55,314,977.51 | 64,392,425.86 |
| 应付账款 | 162,121,413.7 | 120,626,823.03 | 112,977,617.18 | 74,748,862.14 |
| 合同负债 | 11,669,062.09 | 83,593,181.08 | 51,076,712.73 | 10,616,235.32 |
| 应付职工薪酬 | 9,247,499.26 | 6,393,869.82 | 14,760,653.11 | 9,755,459.17 |
| 应交税费 | 33,722,690.77 | 21,847,595.51 | 19,080,417.25 | 13,333,501.01 |
| 其他应付款合计 | 6,961,579.72 | 1,721,774.57 | 1,941,071.68 | 2,068,123.76 |
| 一年内到期的非流动负债 | 1,765,688.81 | 1,756,026.39 | 6,141,964.32 | 30,608,598.96 |
| 其他流动负债 | 7,643,381.88 | 17,462,677.23 | 7,550,145.16 | 2,024,740.29 |
| 流动负债合计 | 499,445,309.92 | 414,064,060.6 | 491,815,889.42 | 467,338,733.83 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 22,440,000 | 80,190,000 |
| 租赁负债 | - | 490,141.11 | 486,059 | 1,420,164.47 |
| 递延收益 | 17,113,272.07 | 10,240,579.57 | 10,484,706.38 | 10,789,044.79 |
| 递延所得税负债 | 241,312.88 | 372,368.53 | 372,843.26 | 1,144,745.9 |
| 非流动负债合计 | 17,354,584.95 | 11,103,089.21 | 33,783,608.64 | 93,543,955.16 |
| 负债合计 | 516,799,894.87 | 425,167,149.81 | 525,599,498.06 | 560,882,688.99 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 143,500,000 | 143,500,000 | 143,500,000 | 107,600,000 |
| 资本公积 | 956,018,870.75 | 955,868,164.13 | 955,240,999.94 | 191,590,089.5 |
| 盈余公积 | 37,647,819.58 | 37,647,819.58 | 37,647,819.58 | 26,948,993.72 |
| 未分配利润 | 592,589,834.51 | 602,268,747.07 | 561,389,690.74 | 548,832,719.16 |
| 归属于母公司股东权益合计 | 1,729,756,524.84 | 1,739,284,730.78 | 1,697,778,510.26 | 874,971,802.38 |
| 少数股东权益 | 3,085,892.3 | 1,998,775.9 | 1,966,323.24 | - |
| 股东权益合计 | 1,732,842,417.14 | 1,741,283,506.68 | 1,699,744,833.5 | 874,971,802.38 |
| 负债和股东权益合计 | 2,249,642,312.01 | 2,166,450,656.49 | 2,225,344,331.56 | 1,435,854,491.37 |
| 公告日期 | 2026-08-24 | 2026-04-29 | 2026-04-10 | 2025-11-04 |
| 审计意见(境内) | | | 标准无保留意见 | |